Exact Mass: 405.1358

Exact Mass Matches: 405.1358

Found 64 metabolites which its exact mass value is equals to given mass value 405.1358, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-Hydroxyphenylacetonitrile triacetylrhamnoside

(2S,3S,4R,5R,6S)-4,5-bis(acetyloxy)-6-[4-(cyanomethyl)phenoxy]-2-methyloxan-3-yl acetate

C20H23NO8 (405.1424)


4-Hydroxyphenylacetonitrile triacetylrhamnoside is a fully acetylated nitrile glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. 4-Hydroxyphenylacetonitrile triacetylrhamnoside is found in brassicas. Constituent of the leaves of the horseradish tree (Moringa oleifera, Moringaceae). 4-Hydroxyphenylacetonitrile triacetylrhamnoside is found in brassicas.

   
   

O-beta-D-galactopyranosyl-(1-->3)-O-beta-D-arabinofuranosyl-(1-->1)-cytosine

O-beta-D-galactopyranosyl-(1-->3)-O-beta-D-arabinofuranosyl-(1-->1)-cytosine

C15H23N3O10 (405.1383)


   

isonaamidine A|isonaamidine-A

isonaamidine A|isonaamidine-A

C21H19N5O4 (405.1437)


   

Di-Me dethioacetal,6-N-benzoyl-Lincosamine

Di-Me dethioacetal,6-N-benzoyl-Lincosamine

C17H27NO6S2 (405.128)


   

Atropine sulfate monohydrate

Benzeneacetic acid, a-(hydroxymethyl)-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate (2:1) (salt),monohydrate

C17H27NO8S (405.1457)


   
   

Prochlorperazine sulfone

Prochlorperazine sulfone

C20H24ClN3O2S (405.1278)


   

4-Hydroxyphenylacetonitrile triacetylrhamnoside

3,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-4-yl acetate

C20H23NO8 (405.1424)


   
   

SEROTONIN CREATININE SULFATE MONOHYDRATE

SEROTONIN CREATININE SULFATE MONOHYDRATE

C14H23N5O7S (405.1318)


5-Hydroxytryptamine creatinine sulfate monohydrate is an endogenous metabolite.

   

Heroin hydrochloride

Heroine hydrochloride

C21H24ClNO5 (405.1343)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

4-NITRODIBENZO-18-CROWN-6

4-NITRODIBENZO-18-CROWN-6

C20H23NO8 (405.1424)


   

Fmoc-D-Phe(3-F)-OH

Fmoc-D-Phe(3-F)-OH

C24H20FNO4 (405.1376)


   
   

fmoc-(s)-3-amino-3-(2-fluoro-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(2-fluoro-phenyl)-propionic acid

C24H20FNO4 (405.1376)


   

fmoc-(r)-3-amino-3-(3-fluoro-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(3-fluoro-phenyl)-propionic acid

C24H20FNO4 (405.1376)


   

1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 2,5-dimethyl ester

1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2,5-pyridinedicarboxylic acid 2,5-dimethyl ester

C20H23NO8 (405.1424)


   

palmatine hydrochloride

palmatine hydrochloride

C21H24ClNO5 (405.1343)


   

fmoc-(r)-3-amino-3-(2-fluoro-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(2-fluoro-phenyl)-propionic acid

C24H20FNO4 (405.1376)


   

Fmoc-Phe(3-F)-OH

Fmoc-Phe(3-F)-OH

C24H20FNO4 (405.1376)


   

2-[[(4-Chlorophenyl) methylhydrazono]methyl]-1-(2-methoxyethyl)-3,3-dimethyl-3H-indolium chloride

2-[[(4-Chlorophenyl) methylhydrazono]methyl]-1-(2-methoxyethyl)-3,3-dimethyl-3H-indolium chloride

C21H25Cl2N3O (405.1375)


   

morclofone

morclofone

C21H24ClNO5 (405.1343)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

fmoc-p-fluoro-dl-phe-oh

fmoc-p-fluoro-dl-phe-oh

C24H20FNO4 (405.1376)


   
   

p-Amidinophenyl p-(6-amidino-2-indolyl)phenyl ether dihydrochloride

p-Amidinophenyl p-(6-amidino-2-indolyl)phenyl ether dihydrochloride

C22H20ClN5O (405.1356)


   

Fmoc-Phe(2-F)-OH

Fmoc-Phe(2-F)-OH

C24H20FNO4 (405.1376)


   

fmoc-(r)-3-amino-3-(4-fluoro-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(4-fluoro-phenyl)-propionic acid

C24H20FNO4 (405.1376)


   

3-n-fmoc-3-(4-fluorophenyl)propionic acid

3-n-fmoc-3-(4-fluorophenyl)propionic acid

C24H20FNO4 (405.1376)


   

3-(2-aminoethyl)-1H-indol-6-ol,2-amino-3-methyl-4H-imidazol-5-one,sulfuric acid

3-(2-aminoethyl)-1H-indol-6-ol,2-amino-3-methyl-4H-imidazol-5-one,sulfuric acid

C14H23N5O7S (405.1318)


   

fmoc-(s)-3-amino-3-(3-fluoro-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(3-fluoro-phenyl)-propionic acid

C24H20FNO4 (405.1376)


   

FMOC-L-4-Fluorophe

FMOC-L-4-Fluorophe

C24H20FNO4 (405.1376)


   

Fmoc-D-4-Fluorophe

Fmoc-D-4-Fluorophe

C24H20FNO4 (405.1376)


   

Fmoc-D-Phe(2-F)-OH

Fmoc-D-Phe(2-F)-OH

C24H20FNO4 (405.1376)


   

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(4-FLUOROPHENYL)PROPANOIC ACID

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(4-FLUOROPHENYL)PROPANOIC ACID

C24H20FNO4 (405.1376)


   

Mazaticol

(6,6,9-trimethyl-9-azabicyclo[3.3.1]nonan-3-yl) 2-hydroxy-2,2-dithiophen-2-ylacetate

C21H27NO3S2 (405.1432)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

4-[(5-{[4-(3-Chlorophenyl)-3-oxopiperazin-1-YL]methyl}-1H-imidazol-1-YL)methyl]benzonitrile

4-[(5-{[4-(3-Chlorophenyl)-3-oxopiperazin-1-YL]methyl}-1H-imidazol-1-YL)methyl]benzonitrile

C22H20ClN5O (405.1356)


   

Acridine mustard free base

Acridine mustard free base

C21H25Cl2N3O (405.1375)


   

H-Glu(Glu(Glu-OH)-OH)-OH

H-Glu(Glu(Glu-OH)-OH)-OH

C15H23N3O10 (405.1383)


   

7,8-dimethyl-4-oxo-10-[(2S,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexyl]benzo[g]pteridin-2-olate

7,8-dimethyl-4-oxo-10-[(2S,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexyl]benzo[g]pteridin-2-olate

C18H21N4O7- (405.141)


   

1-(2-Chloro-4-methylphenyl)-3-[[1-[(3-chlorophenyl)methyl]-4-piperidinyl]methyl]urea

1-(2-Chloro-4-methylphenyl)-3-[[1-[(3-chlorophenyl)methyl]-4-piperidinyl]methyl]urea

C21H25Cl2N3O (405.1375)


   

1-(4-Chlorophenyl)-5-[1-[(2-methylpropan-2-yl)oxy-oxomethyl]-4-piperidinyl]-4-pyrazolecarboxylic acid

1-(4-Chlorophenyl)-5-[1-[(2-methylpropan-2-yl)oxy-oxomethyl]-4-piperidinyl]-4-pyrazolecarboxylic acid

C20H24ClN3O4 (405.1455)


   

1-[1-[4-[(4-chlorophenyl)methoxy]phenyl]-2,5-dimethylpyrrol-3-yl]-N-(1,2,4-triazol-4-yl)methanimine

1-[1-[4-[(4-chlorophenyl)methoxy]phenyl]-2,5-dimethylpyrrol-3-yl]-N-(1,2,4-triazol-4-yl)methanimine

C22H20ClN5O (405.1356)


   

Diethyl 3-methyl-5-[[2-(pyridin-2-ylmethylamino)acetyl]amino]thiophene-2,4-dicarboxylate

Diethyl 3-methyl-5-[[2-(pyridin-2-ylmethylamino)acetyl]amino]thiophene-2,4-dicarboxylate

C19H23N3O5S (405.1358)


   

N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline

N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline

C19H23N3O5S (405.1358)


   

2-(2-Furanylmethylamino)benzoic acid [2-oxo-2-(3-oxo-2,4-dihydroquinoxalin-1-yl)ethyl] ester

2-(2-Furanylmethylamino)benzoic acid [2-oxo-2-(3-oxo-2,4-dihydroquinoxalin-1-yl)ethyl] ester

C22H19N3O5 (405.1325)


   

5-amino-N-(2-methoxy-5-methylphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-4-triazolecarboxamide

5-amino-N-(2-methoxy-5-methylphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-4-triazolecarboxamide

C19H18F3N5O2 (405.1413)


   

2-(Butylamino)benzoic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester

2-(Butylamino)benzoic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester

C19H23N3O5S (405.1358)


   

4-pyrazol-1-yl-N,N-bis(pyridin-2-ylmethyl)benzenesulonamide

4-pyrazol-1-yl-N,N-bis(pyridin-2-ylmethyl)benzenesulonamide

C21H19N5O2S (405.1259)


   

H-gamma-Glu-gamma-Glu-Glu-OH

H-gamma-Glu-gamma-Glu-Glu-OH

C15H23N3O10 (405.1383)


   

4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-[4-(trifluoromethyl)-2-pyridinyl]butanamide

4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-[4-(trifluoromethyl)-2-pyridinyl]butanamide

C20H18F3N3O3 (405.13)


   

[4,5-Diacetyloxy-6-[4-(cyanomethyl)phenoxy]-2-methyloxan-3-yl] acetate

[4,5-Diacetyloxy-6-[4-(cyanomethyl)phenoxy]-2-methyloxan-3-yl] acetate

C20H23NO8 (405.1424)


   

(2E,5Z)-5-{[1-(2,4-difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-2-[(2-methoxyethyl)imino]-3-methyl-1,3-thiazolidin-4-one

(2E,5Z)-5-{[1-(2,4-difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-2-[(2-methoxyethyl)imino]-3-methyl-1,3-thiazolidin-4-one

C20H21F2N3O2S (405.1322)


   

Adenosine, N-(2-hydroxycyclopentyl)-, (1S-trans)-[CAS]

Adenosine, N-(2-hydroxycyclopentyl)-, (1S-trans)-[CAS]

C15H24ClN5O6 (405.1415)


   

Glu-Glu-Glu

Glu-Glu-Glu

C15H23N3O10 (405.1383)


A tripeptide composed of three L-glutamic acid units joined by peptide linkages.

   

ST 18:5;O6;Gly

ST 18:5;O6;Gly

C20H23NO8 (405.1424)


   

JZP-361

JZP-361

C22H20ClN5O (405.1356)


JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research[1]. JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research[1].

   

(2s,3r,4r,5s,6s)-4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate

(2s,3r,4r,5s,6s)-4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate

C20H23NO8 (405.1424)


   

(2s,3r,4s,5r,6r)-2-{[(2r,3s,4s,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(2r,3s,4s,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H23N3O10 (405.1383)


   

2-{[4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H23N3O10 (405.1383)


   

4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate

4,5-bis(acetyloxy)-2-[4-(cyanomethyl)phenoxy]-6-methyloxan-3-yl acetate

C20H23NO8 (405.1424)


   

5-({1,4-bis[(4-hydroxyphenyl)methyl]imidazol-2-yl}imino)-2-hydroxy-3-methylimidazol-4-one

5-({1,4-bis[(4-hydroxyphenyl)methyl]imidazol-2-yl}imino)-2-hydroxy-3-methylimidazol-4-one

C21H19N5O4 (405.1437)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

C15H23N3O10 (405.1383)


   

5-({1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl}amino)-3h-imidazole-2,4-dione

5-({1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl}amino)-3h-imidazole-2,4-dione

C21H19N5O4 (405.1437)